Alpha 2.0
Login Register
» Authors » Andrew Kambugu

Andrew Kambugu

Explore the profile of Andrew Kambugu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 169
Citations 3888
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Science
Top 10 Co-Authors
Barbara Castelnuovo
Mohammed Lamorde
Yukari C Manabe
Robert Colebunders
Joseph Musaazi
Christine Sekaggya-Wiltshire
David R Boulware
David B Meya
Jan Fehr
Moses R Kamya
Published In
J Acquir Immune Defic Syndr
PLoS One
Clin Infect Dis
AIDS
J Int AIDS Soc
Affiliations
Soon will be listed here.
Recent Articles
1.
Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A
Hope M, Kiggundu R, Tabajjwa D, Tumwine C, Lwigale F, Mwanja H, et al.
Wellcome Open Res . 2025 Feb; 9:692. PMID: 39931110
Introduction: The World Health Organization global antimicrobial resistance surveillance system (GLASS) was rolled out in 2015 to guide antimicrobial resistance (AMR) surveillance. However, its implementation in Africa has not been...
2.
Progress of Implementation of World Health Organization Global Antimicrobial Resistance Surveillance System Recommendations on Priority Pathogen-Antibiotic Sensitivity Testing in Africa: Protocol for a Scoping Review
Hope M, Kiggundu R, Byonanebye D, Mayito J, Tabajjwa D, Lwigale F, et al.
JMIR Res Protoc . 2024 Nov; 13:e58140. PMID: 39546786
Background: Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health...
3.
Combating Antimicrobial Resistance Through a Data-Driven Approach to Optimize Antibiotic Use and Improve Patient Outcomes: Protocol for a Mixed Methods Study
Mayito J, Tumwine C, Galiwango R, Nuwamanya E, Nakasendwa S, Hope M, et al.
JMIR Res Protoc . 2024 Nov; 13:e58116. PMID: 39514268
Background: It is projected that drug-resistant infections will lead to 10 million deaths annually by 2050 if left unabated. Despite this threat, surveillance data from resource-limited settings are scarce and...
4.
Utility of syndromic surveillance for the surveillance of healthcare-associated infections in resource-limited settings: a narrative review
Mwanja H, Waswa J, Kiggundu R, Mackline H, Bulwadda D, Byonanebye D, et al.
Front Microbiol . 2024 Nov; 15:1493511. PMID: 39498141
Globally, Healthcare-associated infections (HCAIs) pose a significant threat to patient safety and healthcare systems. In low- and middle-income countries (LMICs), the lack of adequate resources to manage HCAIs, as well...
5.
Survival Following Diagnosis of HIV-Associated Kaposi Sarcoma Among Adults in East Africa in the "Treat-All" Era
Byakwaga H, Semeere A, Laker-Oketta M, Busakhala N, Freeman E, Rotich E, et al.
medRxiv . 2024 Sep; PMID: 39252899
Background: Despite widespread access to antiretroviral therapy (ART) in the "Treat All" era, HIV-associated Kaposi sarcoma (KS) remains among the most common malignancies in sub-Saharan Africa. Survival after KS diagnosis...
6.
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report
Casey R, Najjengo M, Lubega I, Sekiziyivu A, Twinomuhwezi-Oyet E, Nakato W, et al.
Vaccine . 2024 Aug; 42(22):126197. PMID: 39153293
Background: In 2016, the World Health Organization recommended that a fractional dose of yellow fever (YF) vaccine could be used in persons 2 years of age or older in response...
7.
Increased Levels of Caspase-1 and IL-1β Among Adults With Persistent Immune Activation After 12 Years of Suppressive Antiretroviral Therapy in the Infectious Diseases Institute HIV Treatment Cohort
Nabatanzi R, Ssekamatte P, Castelnuovo B, Kambugu A, Nakanjako D
Open Forum Infect Dis . 2023 Nov; 10(11):ofad539. PMID: 37953818
Background: We sought evidence of activated pyroptosis and the inflammasome pathways among human immunodeficiency virus (HIV)-infected adults after 12 years of suppressive antiretroviral therapy (ART) and persistent immune activation in...
8.
Mental disorders and lack of social support among refugees and Ugandan nationals screening for HIV at health centers in Nakivale Refugee Settlement in southwestern Uganda
Klabbers R, Ashaba S, Stern J, Faustin Z, Tsai A, Kasozi J, et al.
J Glob Health Rep . 2023 May; 6. PMID: 37168525
Background: Exposure to potentially traumatic events and daily stressors in humanitarian settings puts refugees and asylum seekers (henceforth collectively referred to as refugees) at increased risk for mental disorders. Little...
9.
Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda
Okoboi S, Musaazi J, King R, Lippman S, Kambugu A, Mujugira A, et al.
PLOS Glob Public Health . 2023 Mar; 2(12):e0000569. PMID: 36962730
Appointment keeping and self-report within 7-day or and 30-days recall periods are non-objective measures of antiretroviral treatment (ART) adherence. We assessed incidence of virological failure (VF), predictive performance and associations...
10.
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda
Omali D, Buzibye A, Kwizera R, Byakika-Kibwika P, Namakula R, Matovu J, et al.
Afr J Lab Med . 2023 Mar; 12(1):1956. PMID: 36873289
Background: Research and clinical use of clinical pharmacology laboratories are limited in low- and middle-income countries. We describe our experience in building and sustaining laboratory capacity for clinical pharmacology at...